Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupus Erythematosus, Systemic
|
1172 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.900 | 0.967 | 30 | 2007 | 2017 | |||||
Rheumatoid Arthritis
|
2387 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.900 | 0.966 | 29 | 2007 | 2017 | |||||
Autoimmune Diseases
|
428 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.900 | 1.000 | 11 | 2008 | 2017 | |||||
Liver carcinoma
|
942 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.900 | 0.909 | 11 | 2013 | 2019 | |||||
Systemic Scleroderma
|
287 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.870 | 0.778 | 9 | 2009 | 2017 | |||||
Primary biliary cirrhosis
|
667 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.810 | 1.000 | 3 | 2012 | 2014 | |||||
Immune System Diseases
|
116 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||
Biliary cirrhosis
|
36 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Multiple Sclerosis
|
1022 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Sjogren's Syndrome
|
47 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||
SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11
|
1 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 0 | ||||||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.070 | 0.571 | 7 | 2008 | 2015 | |||||
Complete atrioventricular block
|
96 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.060 | 1.000 | 6 | 2013 | 2019 | |||||
Crohn Disease
|
1147 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.050 | 0.800 | 5 | 2010 | 2015 | |||||
Hepatitis B
|
519 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.050 | 1.000 | 5 | 2015 | 2020 | |||||
Inflammatory Bowel Diseases
|
605 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.040 | 1.000 | 4 | 2008 | 2015 | |||||
Ulcerative Colitis
|
827 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.040 | 0.750 | 4 | 2008 | 2015 | |||||
Hepatitis B, Chronic
|
84 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.030 | 1.000 | 3 | 2015 | 2019 | |||||
Primary Sjögren's syndrome
|
42 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.030 | 0.667 | 3 | 2010 | 2013 | |||||
Aplastic Anemia
|
30 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2012 | 2018 | |||||
Graves Disease
|
352 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2014 | 2018 | |||||
Hepatitis B Virus-Related Hepatocellular Carcinoma
|
8 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Hepatitis C
|
347 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2013 | 2013 | |||||
Juvenile arthritis
|
128 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 0.500 | 2 | 2013 | 2015 | |||||
Juvenile rheumatoid arthritis
|
10 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 0.500 | 2 | 2013 | 2015 |